https://www.thebodypro.com/category/hiv-treatments-in-development
HIV Treatment Strategies

HIV Treatments in Development

The Latest

Fauci discusses Remdesivir
News Analysis

We Need to Temper Expectations for Remdesivir as COVID-19 Treatment

Because the public is getting so many mixed messages, it’s our responsibility to provide clarity and moderate optimism.

By Kenyon Farrow
Shahin Lockman.
Interviews

Whether HIV or COVID-19, Pregnant or Lactating Cisgender Women Need to Be Included in Clinical Trials for Therapies

Dr. Shahin Lockman says to not include women in trials is unethical.

By Terri Wilder, M.S.W.
injectable
Conference Coverage

The Monthly Injectable HIV Drug Works Just as Well When Given Every Two Months

Although injectable cabotegravir/rilpivirine is still yet to be approved by the FDA, evidence keeps mounting on the effectiveness of the shot for HIV treatment.

By Sony Salzman
stem cell transplant device
Conference Coverage

Durable HIV Remission in London Patient, the Second Person Cured of HIV

Researchers are happy but cautious, because this isn’t a strategy for most people with HIV.

By Sony Salzman
injectable
News

Long-Acting Injectable HIV Meds Just as Good as Daily Pill for Newly Diagnosed and Those Already Undetectable

Questions still remain as to when FDA will approve, and how it will be implemented.

By Kenyon Farrow
Marrazzo at CROI
News

CROI 2020: What to Expect in HIV Science From This Year’s Conference

COVID-19 will impact both the program content and attendees this year, but there are still important HIV science presentations.

By Sony Salzman
pregnant woman and partner cuddling on couch
News

New Study Will Test Safety of PrEP and Dapivirine Ring in Pregnancy

While the vaginal ring is still currently under FDA review, the new study will show whether it is safe and acceptable for people who are pregnant.

By Martha Kempner
doctor getting ready to give patient vaccine
News Analysis

HIV Vaccine Trial Stopped Early, but Research Into Other Approaches Continues

HVTN 702 is but one of many vaccine trials underway, researchers note.

By Barbara Jungwirth
Toby Pepperrell
Interviews

Is Virologic Failure the Best Endpoint in Clinical Trials for Integrase Inhibitors?

Using data from the ADVANCE trial, this researcher suggests people with HIV with low-level viremia may still get to undetectable.

By Terri Wilder, M.S.W.
syringe going into vial
News Analysis

FDA Rejects Injectable HIV Treatment, but Not Due to Drug Safety

This may be a temporary setback, but long-acting antiretroviral therapy is still on the way, experts say.

By Larry Buhl